Results 231 to 240 of about 114,692 (269)

Glucagon: a potential protective factor against peripheral nerve compromise in patients with type 2 diabetes and obesity. [PDF]

Diabetol Metab Syndr
Hua H, Wang R, Xu YX, Xu F, Wang CH, Zhao LH, Wang LH, Duan CW, Su JB.   +8 more
europepmc   +1 more source

Glucagon treatment stimulates the metabolism of hepatic submitochondrial particles.

, 1978
M A Titheradge, Sue Binder, Russell K. Yamazaki, R C Haynes   +3 more
openalex   +1 more source

Pancreatic stem cells originate during the pancreatic progenitor developmental stage. [PDF]

Front Cell Dev Biol
Jacques K, Coles BLK, van der Kooy D.
europepmc   +1 more source

Glucagon and barium enema examinations: a controlled clinical trial

, 1976
RK Harned, C B Stelling, S Mark Williams, G. Wolf   +3 more
openalex   +1 more source

Microscopy and spectroscopy approaches to study GPCR structure and function

British Journal of Pharmacology, EarlyView.
Abstract The GPCR signalling cascade is a key pathway responsible for the signal transduction of a multitude of physical and chemical stimuli, including light, odorants, neurotransmitters and hormones. Understanding the structural and functional properties of the GPCR cascade requires direct observation of signalling processes in high spatial and ...
Tomáš Fessl, Maria Majellaro, Alexey Bondar   +2 more
wiley   +1 more source

Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Heart Disease: Effect, Safety, and Outcomes. [PDF]

JACC Adv
Thapa R, Lara-Breitinger KM, Lopez-Jimenez F, Shama N, Egbe AC, Miranda WR, Connolly HM, Jain CC, Jokhadar M, Kosec AM, Alm S, Burchill LJ.   +11 more
europepmc   +1 more source

Arrestin‐centred interactions at the membrane and their conformational determinants

British Journal of Pharmacology, EarlyView.
Abstract More than 30 years after their discovery, arrestins are recognised multiprotein scaffolds that play essential roles in G protein‐coupled receptor (GPCR) regulation and signalling. Originally named for their capacity to hinder GPCR coupling to G proteins and facilitate receptor desensitisation, arrestins have emerged as key hubs for a myriad of
Owen Underwood, Raphael Silvanus Haider, Julie Sanchez, Meritxell Canals   +3 more
wiley   +1 more source

Tracking Insulin- and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line. [PDF]

Diabetes
Mar S, Filatov E, Sasaki S, Mojibian M, Zhang D, Yang A, Nian C, Lynn FC.   +7 more
europepmc   +1 more source

Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China

British Journal of Pharmacology, EarlyView.
Abstract Liver disease constitutes a significant global health concern, particularly in China where it has distinctive characteristics. China grapples with a staggering 300 million cases, predominantly due to hepatitis B and metabolic non‐alcoholic fatty liver disease. Additionally, hepatocellular carcinoma has become a prevalent which is a lethal type
Feng Zhang, Jiaming Ju, Hongtao Diao, Jinglun Song, Yu bian, Baofeng Yang   +5 more
wiley   +1 more source

Glucagon-Like Peptide-1 Is Prognostic of Mortality in Acute Respiratory Failure. [PDF]

Crit Care Explor
Hansell CE, Aneis HA, Kitsios GD, Bain WG, Zhao Y, Suber TL, Evankovich JW, Sharma L, Ramakrishnan SK, Prendergast NT, Hensley MK, Malik S, Petro N, Patel JJ, Nouraie SM, Dela Cruz CS, Zhang Y, McVerry BJ, Shah FA.   +18 more
europepmc   +1 more source